Home › Funds › Candriam S.C.A. › AMGN

Candriam S.C.A. position in AMGN

AMGEN INC · Health Care

Candriam S.C.A. reported holding 352,483 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$149.1M, representing 0.67% of its reported portfolio and ranking #28 among its reported holdings. Candriam S.C.A. has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)352.48K sh
Reported value held$149.12M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Candriam S.C.A.'s AMGN position evolved

Candriam S.C.A. first disclosed a stake in AMGN in Q3 2023 at 861,737 shares (US$231.6M). The position peaked in Q3 2024 at 813,096 shares, worth US$262.0M. Across 13 filings, Candriam S.C.A. increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 352,483 shares valued at US$149.1M — a reduction of -10,502 shares quarter over quarter.. Notable position changes include a 33% increase in Q3 2024 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 861.74K $231.60M New
Q4 2023 759.42K $218.74M Reduce
Q1 2024 688.36K $195.71M Reduce
Q2 2024 610.17K $190.64M Reduce
Q3 2024 813.10K $261.98M Add
Q4 2024 617.52K $160.95M Reduce
Q1 2025 506.20K $157.71M Reduce
Q2 2025 505.72K $141.21M Hold
Q3 2025 445.22K $125.64M Reduce
Q4 2025 391.74K $128.22M Reduce
Q1 2026 395.35K $139.10M Add
Q2 2026 362.99K $131.32M Reduce
Q3 2026 352.48K $149.12M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 30 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), VANGUARD CAPITAL MANAGEMENT LLC (US$14.92B), STATE STREET CORP (US$13.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has Candriam S.C.A. held AMGN?

Candriam S.C.A. has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Candriam S.C.A.'s current position in AMGN?

As of Q3 2026, Candriam S.C.A. holds 352.48K shares of AMGN (AMGEN INC), valued at $149.12M, representing 0.67% of its reported portfolio and ranking #28.

Has Candriam S.C.A. been buying or selling AMGN?

In the latest 13F filing (Q3 2026), Candriam S.C.A. reduced its position in AMGN. The position peaked in Q3 2024 at 813.10K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.